FSB Premier Wealth Management
GSK icon

FSB Premier Wealth Management’s GSK GSK Stock Holding History

FSB Premier Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$243K Buy
5,048
+139
+3% +$7.1K 0.06% 237
2026
Q2 		$257K Buy
4,909
+448
+10% +$23.7K 0.07% 226
2026
Q1 		$246K Sell
4,461
-357
-7% -$19.3K 0.08% 224
2025
Q4 		$236K Sell
4,818
-122
-2% -$5.69K 0.08% 214
2025
Q3 		$213K Buy
+4,940
New +$193K 0.07% 219
2022
Q1 		– Sell
-436
Closed -$24K – 315
2021
Q4 		$24K Buy
+436
New +$22.7K 0.01% 324

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $187B AUM 13.73% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return
JTC Employer Solutions Trustee
JTC Employer Solutions Trustee St Helier, Jersey $1.16B AUM 24.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Mondrian Investment Partners
Mondrian Investment Partners London, United Kingdom $5.39B AUM 14.53% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $46.6B AUM 32.12% 1-Year Est. Return

FSB Premier Wealth Management's GSK Position: Q3 2026 in Review

FSB Premier Wealth Management increased its GSK (GSK) stake by 2.8% in Q3 2026, buying an estimated $7.1K and bringing the position to 5,048 shares worth $243K. The position accounts for 0.06% of the portfolio, ranked #237.

FSB Premier Wealth Management first reported a position in GSK in Q4 2021 and has held it in 6 quarters since. The position peaked at $257K in Q2 2026. 854 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • FSB Premier Wealth Management held 5,048 shares of GSK worth $243K as of Q3 2026.
  • FSB Premier Wealth Management bought 139 GSK shares in Q3 2026, an estimated $7.1K.
  • GSK made up 0.06% of FSB Premier Wealth Management's portfolio in Q3 2026, its #237 holding.
  • FSB Premier Wealth Management first reported a position in GSK in Q4 2021 and has held it in 6 quarters since.
  • FSB Premier Wealth Management's GSK position peaked at $257K in Q2 2026.
  • 854 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on FSB Premier Wealth Management's 13F filing for Q3 2026, filed 13 Nov 2026.